(Q49121891)

18 February 2018

title

Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model. (English)

1 reference

18 February 2018

0 references

0 references

0 references

1 reference

2

1 reference

18 February 2018

Rudi Beyaert

5

1 reference

18 February 2018

Karim El Bakkouri

object named as

Karim El Bakkouri

1

0 references

Karen Heyninck

4

object named as

Karen Heyninck

1 reference

18 February 2018

author name string

Mira Haegman

3

1 reference

18 February 2018

language of work or name

English

0 references

publication date

18 February 2005

1 reference

18 February 2018

Journal of Biological Chemistry

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 February 2018

volume

280

1 reference

18 February 2018

issue

18

1 reference

18 February 2018

page(s)

17938-17944

1 reference

18 February 2018

https://api.crossref.org/works/10.1074%2FJBC.M413588200

1 reference

Th2 cytokines and asthma: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

IkappaB kinases: key regulators of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

New asthma drugs acting on gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Cytokine-directed therapies for the treatment of chronic airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Early-Onset Inflammatory ResponsesIn Vivoto Adenoviral Vectors in the Presence or Absence of Lipopolysaccharide-Induced Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Glucocorticoids: new mechanisms and future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M413588200

21 January 2018

Identifiers

DOI

10.1074/JBC.M413588200

1 reference

18 February 2018

1 reference

18 February 2018